Literature DB >> 17389696

Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.

Manuel Luque-Ramírez1, Francisco Alvarez-Blasco, Covadonga Mendieta-Azcona, José I Botella-Carretero, Héctor F Escobar-Morreale.   

Abstract

CONTEXT: Obesity and insulin resistance predispose patients with the polycystic ovary syndrome (PCOS) to abnormalities in blood pressure regulation.
OBJECTIVE: Our objective was to evaluate the impact of obesity on the blood pressure profiles of PCOS patients. PATIENTS, SETTING, AND
DESIGN: Thirty-six PCOS patients and 20 healthy women participated in a case-control study at an academic hospital. MAIN OUTCOME MEASURES: We conducted ambulatory blood pressure monitoring and office blood pressure determinations.
RESULTS: Hypertension (defined as increased office blood pressure confirmed by ambulatory blood pressure monitoring or by masked hypertension) was present in 12 PCOS patients and eight controls (P = 0.618). No differences between patients and controls were found in office and ambulatory blood pressure monitoring values and heart rate, yet the nocturnal decrease in mean blood pressure was smaller in patients (P = 0.038). Obese women (13 patients and eight controls) had increased frequencies of office hypertension (29% compared with 3% in lean plus overweight women, P = 0.005), increased diastolic (P = 0.009) and mean (P = 0.015) office blood pressure values, and increased heart rate values during the daytime (P = 0.038), nighttime (P = 0.002), and 24-h (P = 0.009) periods, independently of having PCOS or not. The frequency of a nocturnal nondipper pattern was 62% in obese PCOS patients, compared with 26% in lean plus overweight PCOS patients (P = 0.036) and 25% in obese and in lean plus overweight controls.
CONCLUSIONS: Abnormalities in the regulation of blood pressure are common in young women with PCOS, yet, with the exception of the nondipper pattern, these abnormalities result from the frequent association of this syndrome with obesity.

Entities:  

Mesh:

Year:  2007        PMID: 17389696     DOI: 10.1210/jc.2007-0190

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Ovarian hypertension: polycystic ovary syndrome.

Authors:  Rhonda Bentley-Lewis; Ellen Seely; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

2.  Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome.

Authors:  Hasan Kadi; Eyup Avci; Akin Usta; Abdullah Orhan Demirtaş
Journal:  Reprod Biol Endocrinol       Date:  2018-08-09       Impact factor: 5.211

Review 3.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 4.  Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

Authors:  Katie Nitsche; David A Ehrmann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-10       Impact factor: 4.690

Review 5.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 6.  Polycystic ovary syndrome in the pediatric population.

Authors:  Andrew A Bremer
Journal:  Metab Syndr Relat Disord       Date:  2010-10       Impact factor: 1.894

7.  Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome.

Authors:  Carley A Gomez-Meade; Gabriela Lopez-Mitnik; Sarah E Messiah; Kristopher L Arheart; Adriana Carrillo; Nestor de la Cruz-Muñoz
Journal:  World J Diabetes       Date:  2013-06-15

8.  Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.

Authors:  Meri-Maija E Ollila; Kari Kaikkonen; Marjo-Riitta Järvelin; Heikki V Huikuri; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Laure Morin-Papunen
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

9.  Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Ethel Codner; Virginia Pérez; Bárbara Echiburú; Manuel Maliqueo; Amanda Ladrón de Guevara; Jessica Preisler; Nicolás Crisosto; Fernando Sánchez; Fernando Cassorla; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2009-02-17       Impact factor: 5.958

10.  Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.

Authors:  Roberto Mioni; Anna Dalla Cà; Jenni Turra; Sara Azzolini; Nadia Xamin; Luigi Bleve; Pietro Maffei; Roberto Vettor; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-03       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.